Literature DB >> 25934265

In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts.

Joachim Müller1, Vreni Balmer1, Pablo Winzer1, Mahbubur Rahman1, Vera Manser1, Richard K Haynes2, Andrew Hemphill3.   

Abstract

From a panel of 34 artemisinin derivatives tested in vitro, artemisone, GC007 and GC012 were most efficacious at inhibiting Neospora caninum replication (IC50 values of 3-54nM), did not notably impair the invasiveness of tachyzoites and were non-toxic for human foreskin fibroblasts (HFFs). Transmission electron microscopy of drug-treated N. caninum-infected HFFs demonstrated severe alterations in the parasite cytoplasm, changes in the composition of the matrix of the parasitophorous vacuole (PV) and diminished integrity of the PV membrane. To exert parasiticidal activity, parasites had to be cultured continuously in the presence of 5μM artemisone or GC007 for 3 weeks. N. caninum tachyzoites readily adapted to a stepwise increase in concentrations (0.5-10μM) of GC012, but not to artemisone or GC007. Drugs induced the expression of elevated levels of NcBAG1 and NcSAG4 mRNA, but only NcBAG1 could be detected by immunofluorescence. Thus, artemisinin derivatives represent interesting leads that should be investigated further.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Artemisinin; Artemisone; Chemotherapy; Neospora caninum; Resistance; Trioxolane

Mesh:

Substances:

Year:  2015        PMID: 25934265     DOI: 10.1016/j.ijantimicag.2015.02.020

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Experimental infection with Toxoplasma gondii in broiler chickens (Gallus domesticus): seroconversion, tissue cyst distribution, and prophylaxis.

Authors:  Maria E Nedişan; Adriana Györke; Cristina L Ştefănuţ; Zsuzsa Kalmár; Zsuzsa Friss; Radu Blaga; Amandine Blaizot; Andra Toma-Naic; Viorica Mircean; Gereon Schares; Olgica Djurković-Djaković; Ivana Klun; Isabelle Villena; Vasile Cozma
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

2.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

3.  Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Vreni Balmer; Dustin J Maly; Erkang Fan; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C Van Voorhis; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Drug target identification in protozoan parasites.

Authors:  Joachim Müller; Andrew Hemphill
Journal:  Expert Opin Drug Discov       Date:  2016-06-16       Impact factor: 6.098

Review 5.  Artemisinin and its derivatives in treating protozoan infections beyond malaria.

Authors:  Cecilia Shi Ni Loo; Nelson Siu Kei Lam; Deying Yu; Xin-Zhuan Su; Fangli Lu
Journal:  Pharmacol Res       Date:  2016-11-17       Impact factor: 7.658

6.  In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm.

Authors:  Francesca Sisto; Simone Carradori; Sarah D'Alessandro; Nadia Santo; Norma Lattuada; Richard K Haynes; Donatella Taramelli; Rossella Grande
Journal:  Pathogens       Date:  2022-06-29

7.  Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Vera Manser; Ho Ning Wong; Richard K Haynes; Andrew Hemphill
Journal:  Vet Res       Date:  2016-02-17       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.